BG50278A3 - Method for the preparation of (1h- azole- 1- ilmethyl)- substituted benzotriazole derivatives - Google Patents

Method for the preparation of (1h- azole- 1- ilmethyl)- substituted benzotriazole derivatives

Info

Publication number
BG50278A3
BG50278A3 BG084328A BG8432888A BG50278A3 BG 50278 A3 BG50278 A3 BG 50278A3 BG 084328 A BG084328 A BG 084328A BG 8432888 A BG8432888 A BG 8432888A BG 50278 A3 BG50278 A3 BG 50278A3
Authority
BG
Bulgaria
Prior art keywords
azole
preparation
benzotriazole derivatives
ilmethyl
substituted benzotriazole
Prior art date
Application number
BG084328A
Other languages
Bulgarian (bg)
English (en)
Inventor
Alfons Herman Raeymaekers
Eddy Jean Freyne
Josephus Ludovicus Huber Gelder
Marc Venet
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BG50278A3 publication Critical patent/BG50278A3/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BG084328A 1987-06-01 1988-05-31 Method for the preparation of (1h- azole- 1- ilmethyl)- substituted benzotriazole derivatives BG50278A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5602187A 1987-06-01 1987-06-01

Publications (1)

Publication Number Publication Date
BG50278A3 true BG50278A3 (en) 1992-06-15

Family

ID=22001654

Family Applications (2)

Application Number Title Priority Date Filing Date
BG084328A BG50278A3 (en) 1987-06-01 1988-05-31 Method for the preparation of (1h- azole- 1- ilmethyl)- substituted benzotriazole derivatives
BG098159A BG60429B2 (bg) 1987-06-01 1993-10-18 (1н-азол-1-илметил)заместени бензотриазолни производни

Family Applications After (1)

Application Number Title Priority Date Filing Date
BG098159A BG60429B2 (bg) 1987-06-01 1993-10-18 (1н-азол-1-илметил)заместени бензотриазолни производни

Country Status (24)

Country Link
EP (1) EP0293978B1 (lv)
JP (1) JPH0662612B2 (lv)
KR (1) KR970000952B1 (lv)
CN (1) CN1022184C (lv)
AU (1) AU603446B2 (lv)
BG (2) BG50278A3 (lv)
CA (1) CA1307271C (lv)
CY (1) CY1866A (lv)
DE (1) DE3884055T2 (lv)
DK (1) DK175218B1 (lv)
ES (1) ES2059490T3 (lv)
FI (1) FI90078C (lv)
HK (1) HK114795A (lv)
HU (2) HU201056B (lv)
IE (1) IE61823B1 (lv)
IL (1) IL86551A (lv)
LT (1) LT3950B (lv)
LV (1) LV10452B (lv)
NO (1) NO169900C (lv)
NZ (1) NZ224714A (lv)
PT (1) PT87623B (lv)
RU (1) RU1838308C (lv)
UA (1) UA11192A (lv)
ZA (1) ZA883861B (lv)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2002859C (en) * 1988-11-29 1998-12-29 Jean P. F. Van Wauwe Method of treating epithelial disorders
US5157046A (en) * 1988-11-29 1992-10-20 Janssen Pharmaceutica N.V. Method of treating epithelial disorders
GB8827820D0 (en) * 1988-11-29 1988-12-29 Janssen Pharmaceutica Nv (1h-azol-1-ylmethyl)substituted quinoline derivatives
EP0408509B1 (de) * 1989-07-14 1996-03-06 Ciba-Geigy Ag Substituierte Benzonitrile
CA2026792A1 (en) * 1989-11-01 1991-05-02 Michael N. Greco (6,7-dihydro-5h-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1h-benzotriazole derivatives
US5066656A (en) * 1989-11-01 1991-11-19 Janssen Pharmaceutica N.V. Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
NZ236440A (en) * 1989-12-15 1993-07-27 Merck & Co Inc Reversal of sexual phenotype in poultry using an inhibitor of steroid biotransformation and/or aromatase inhibitor, poultry produced by this process
EP0445073A1 (de) * 1990-02-27 1991-09-04 Ciba-Geigy Ag Benzofurane
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
EP0457716A1 (de) * 1990-04-20 1991-11-21 Ciba-Geigy Ag Naphthalinderivate
TW224461B (lv) * 1990-09-18 1994-06-01 Ciba Geigy Ag
US5162337A (en) * 1990-10-05 1992-11-10 Merck & Co., Inc. Animal growth promotion
TW210334B (lv) * 1990-12-12 1993-08-01 Ciba Geigy Ag
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
DE69230225T2 (de) 1991-09-02 2000-05-31 Yamanouchi Pharmaceutical Co., Ltd. Triazolylierte tertiäre aminverbindungen oder ihre salze
US5635521A (en) * 1991-09-23 1997-06-03 Sandoz Ltd. Imidazolylmethyl-pyridines
JP2700595B2 (ja) * 1992-05-21 1998-01-21 呉羽化学工業株式会社 アゾール誘導体を含有する抗アロマターゼ剤
HUT72073A (en) * 1992-11-10 1996-03-28 Janssen Pharmaceutica Nv Process for preparing enantiomerically pure 6-[(4-chlorophenyl)(1h-1,2,4-triazol-1-yl)methyl]-1-methyl-1h-benzotriazole
AU682947B2 (en) * 1994-05-27 1997-10-23 Mochida Pharmaceutical Co., Ltd. Novel azolyl methyl phenyl derivatives having aromatase inhibitory activity
AU6821196A (en) * 1995-08-14 1997-03-12 Janssen Pharmaceutica N.V. Transdermal administration of vorozole
IT1286866B1 (it) * 1996-10-28 1998-07-17 Menarini Farma Ind Composti furano-eterociclici,loro preparazione ed uso come inibitori di aromatasi
KR100559816B1 (ko) * 1996-12-24 2006-03-10 쥬가이 세이야쿠 가부시키가이샤 Nos 저해작용을 가진 방향족 아민 유도체
WO2002000648A1 (fr) * 2000-06-28 2002-01-03 Ssp Co., Ltd. Derives imidazole ou sels de ces derniers, et medicaments contenant les derives ou les sels
US7135575B2 (en) 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
US7521447B2 (en) * 2003-03-03 2009-04-21 Array Biopharma Inc. P38 inhibitors and methods of use thereof
CA2594477C (en) 2005-01-21 2016-07-12 Astex Therapeutics Limited Pharmaceutical compounds
EP1874304B1 (en) * 2005-04-29 2009-07-15 Janssen Pharmaceutica N.V. Benzotriazole derivatives as cannabinoid receptor antagonists
US7572807B2 (en) * 2005-06-09 2009-08-11 Bristol-Myers Squibb Company Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
JP5238504B2 (ja) 2005-09-15 2013-07-17 カウンシル・オブ・サイエンティフィック・アンド・インダストリアル・リサーチ イミダゾリル基で置換された新規なステロイド誘導体およびインダン−1−オン誘導体
SG175599A1 (en) 2006-01-31 2011-11-28 Array Biopharma Inc Kinase inhibitors and methods of use thereof
WO2008044045A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
JP5528806B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
US9394290B2 (en) * 2010-10-21 2016-07-19 Universitaet Des Saarlandes Campus Saarbruecken Selective CYP11B1 inhibitors for the treatment of cortisol dependent diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR75101B (lv) * 1980-10-23 1984-07-13 Pfizer
US4659730A (en) * 1984-06-18 1987-04-21 Eli Lilly And Company Aromatase inhibiting imidazole derivatives
EP0165781A1 (en) * 1984-06-18 1985-12-27 Eli Lilly And Company Aromatase inhibiting N-substituted imidazole derivatives
US4609666A (en) * 1984-06-18 1986-09-02 Eli Lilly And Company Aromatase inhibiting derivatives of α,α-bis(4-halophenyl)methyltetrazoles and triazoles
US4602025A (en) * 1984-06-18 1986-07-22 Eli Lilly And Company Aromatase inhibitors
US4801594A (en) * 1984-06-18 1989-01-31 Eli Lilly And Company Aromatase inhibitors
DE3744589C1 (de) 1987-12-31 1988-12-29 Albrecht Josef Bohrfutter Nachspannendes Bohrfutter

Also Published As

Publication number Publication date
IL86551A0 (en) 1988-11-15
CN88103408A (zh) 1988-12-14
RU1838308C (ru) 1993-08-30
EP0293978A3 (en) 1990-06-13
AU1653788A (en) 1988-12-01
HK114795A (en) 1995-07-21
KR890000469A (ko) 1989-03-14
HU201056B (en) 1990-09-28
PT87623A (pt) 1988-06-01
FI882552A0 (fi) 1988-05-31
CN1022184C (zh) 1993-09-22
DE3884055T2 (de) 1994-01-27
LV10452A (lv) 1995-02-20
FI90078B (fi) 1993-09-15
CY1866A (en) 1988-05-26
NO882390D0 (no) 1988-05-31
BG60429B2 (bg) 1995-03-31
JPH0662612B2 (ja) 1994-08-17
NO169900B (no) 1992-05-11
PT87623B (pt) 1992-09-30
LTIP1625A (en) 1995-07-25
KR970000952B1 (ko) 1997-01-21
EP0293978A2 (en) 1988-12-07
NO882390L (no) 1988-12-02
ES2059490T3 (es) 1994-11-16
CA1307271C (en) 1992-09-08
DE3884055D1 (de) 1993-10-21
HU211482A9 (en) 1995-11-28
LV10452B (en) 1995-08-20
UA11192A (uk) 1996-12-25
JPS63316775A (ja) 1988-12-26
DK175218B1 (da) 2004-07-12
IE881640L (en) 1988-12-01
EP0293978B1 (en) 1993-09-15
FI90078C (fi) 1993-12-27
ZA883861B (en) 1990-01-31
FI882552A (fi) 1988-12-02
IL86551A (en) 1992-07-15
AU603446B2 (en) 1990-11-15
NZ224714A (en) 1990-03-27
HUT49132A (en) 1989-08-28
NO169900C (no) 1992-08-19
LT3950B (en) 1996-05-27
DK295288A (da) 1988-12-02
DK295288D0 (da) 1988-05-31
IE61823B1 (en) 1994-11-30

Similar Documents

Publication Publication Date Title
BG50278A3 (en) Method for the preparation of (1h- azole- 1- ilmethyl)- substituted benzotriazole derivatives
FI94340C (fi) Menetelmä farmakologisesti vaikuttavien 1,5-diaryyli-3-(w-substituoitu-alempi-alkyyli)-pyratsolien valmistamiseksi
BG45701A3 (en) Method for preparing of alpha- heterocyclic substituted tolunitriles
BG41130A3 (en) Method for preparing 8- chlor-1, 5- benzo- thiazepine derivatives
FI884626A0 (fi) Menetelmä terapeuttisesti käyttökelpoisen 4H-1-bentsopyran-4-onijohdoksen tai sen suolan valmistamiseksi ja menetelmässä käyttökelpoinen välituote
PT80157B (en) Methods of treating viral diseases with pyridazinamines anti-virally active pyridazinamines
DE68901043D1 (de) Waessriges pharmazeutisches praeparat.
GR900100380A (el) Μέ?οδος παρασκευής αντι-φλεγμονωδών παραγώγων αμινοφενόλης.
ES525786A0 (es) Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina
AU526270B2 (en) Acid addition salt of 2beta,16beta diperidino 5 alpha androstane derivatives
DE3873197D1 (de) Leitungsmetallisierung von substraten mittels entwicklungsmittel.
IL63190A0 (en) Imidazole derivatives,processes for their manufacture and pharmaceutical preparations containing them
ES8304919A1 (es) Un procedimiento para la preparacion de dicloroamino-acidos.
IT7926964A0 (it) Procedimento per la produzione di derivati dell'acido fenossicarbossilico.
ES478874A1 (es) Procedimiento de preparar 3-0(beta -d-glucuronopiranosil)- soja-sapogenol b.
ES8307249A1 (es) Procedimiento de preparacion de nuevos derivados del adamantano.
ES2074178T3 (es) Preparados de antimicoticos externos de imidazol.
FI93216C (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
FR2356658A1 (fr) Procede de production d'acides phosphinico-carboxyliques aliphatiques substitues
BG40653A3 (en) Method for preparing amidothiocarbamate derivatives of carbon acid
IT7819945A0 (it) Procedimento per la produzione di derivati dell'indolina.
BG39977A3 (en) Method for preparing derivatives of furyloxazolylacetic acid
GR1001566B (el) Μέ?οδος παρασκευής νέων παραγώγων βενζοφουρανυλιμιδαζόλης.
SE7612332L (sv) Sett att framstella nya imidazolderivat.
ES8300747A1 (es) Procedimiento para la preparacion de derivados de acido in- dolacetico